Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.WL Gore & Associates has received the US Food and Drug Administration (FDA) approval for Gore C3 Delivery System, which is used to deploy the Gore Excluder AAA Endoprosthesis as minimally invasive treatment for patients with abdominal aortic aneurysm (AAA).
Subscribe to our email newsletter
The GORE C3 Delivery System allows physicians and interventionalists to reposition the Gore Excluder Device before the final release of the delivery catheter.
The deployment control of the system provides the physician with increased confidence in treating challenging anatomies and also offers cannulation options.
Gore Aortic Business Unit leader David Abeyta said that the Gore C3 Delivery System for the Gore Excluder Device has shown a high level of performance and has demonstrated that it will provide physicians with added confidence and control during endovascular procedures.